HARBI1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.819800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.112200E-01
Normal-vs-Stage2
4.797000E-01
Normal-vs-Stage3
7.041600E-01
Normal-vs-Stage4
4.093600E-01
Stage1-vs-Stage2
7.096000E-01
Stage1-vs-Stage3
1.987840E-01
Stage1-vs-Stage4
5.887000E-01
Stage2-vs-Stage3
1.645580E-01
Stage2-vs-Stage4
5.547200E-01
Stage3-vs-Stage4
2.761000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.002600E-01
Normal-vs-AfricanAmerican
4.002800E-01
Normal-vs-Asian
6.448200E-01
Caucasian-vs-AfricanAmerican
9.670000E-01
Caucasian-vs-Asian
9.047000E-01
AfricanAmerican-vs-Asian
9.697200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.315400E-01
Normal-vs-Female
4.463800E-01
Male-vs-Female
5.467400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.176000E-01
Normal-vs-Age(41-60Yrs)
2.962400E-01
Normal-vs-Age(61-80Yrs)
5.787200E-01
Normal-vs-Age(81-100Yrs)
6.459200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.858600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.863400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.774400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.605000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.914400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.467000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.893000E-01
Normal-vs-Daily Drinker
9.605600E-01
Normal-vs-Weekly Drinker
7.528600E-01
Normal-vs-Occasional Drinker
1.492440E-01
Normal-vs-Social Drinker
1.704800E-01
Non Drinker-vs-Daily Drinker
6.464800E-01
Non Drinker-vs-Weekly Drinker
9.393600E-01
Non Drinker-vs-Occasional Drinker
5.622300E-02
Non Drinker-vs-Social Drinker
1.690160E-01
Daily Drinker-vs-Weekly Drinker
6.457800E-01
Daily Drinker-vs-Occasional Drinker
2.410100E-02
Daily Drinker-vs-Social Drinker
7.666100E-02
Weekly Drinker-vs-Occasional Drinker
9.909600E-02
Weekly Drinker-vs-Social Drinker
2.189200E-01
Occasional Drinker-vs-Social Drinker
5.669200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.165400E-01
Normal-vs-Grade 2
7.372200E-02
Normal-vs-Grade 3
5.581500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.306500E-02
Grade 1-vs-Grade 3
2.514300E-02
Grade 1-vs-Grade 4
2.165400E-01
Grade 2-vs-Grade 3
6.411600E-01
Grade 2-vs-Grade 4
7.372200E-02
Grade 3-vs-Grade 4
5.581500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.780000E-01
Normal-vs-NonDiabetic
4.863600E-01
Diabetic-vs-NonDiabetic
2.901000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.979200E-01
Normal-vs-NoPancreatitis
5.702000E-01
Pancreatitis-vs-NoPancreatitis
7.127400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.018200E-01
Normal-vs-N1
4.973200E-01
N0-vs-N1
6.898200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.251190E-01
Normal-vs-TP53-NonMutant
4.184200E-01
TP53-Mutant-vs-TP53-NonMutant
4.053500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
